| Apria Healthcare Llc | |
| 73 Eastern Steel Rd, Milford, Connecticut 06460 | |
| (203) 877-2249 |
| Name | Apria Healthcare Llc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 73 Eastern Steel Rd, Milford, Connecticut 06460 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (203) 877-2249 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
California Insurance Commissioner Dave Jones denied Blue Shield of California's plan to close several of its health policies to new customers, saying it violated state rules designed to protect consumers from large rate increases. ... Blue Shield, a nonprofit insurer with 3.3 million members statewide, had proposed closing off new enrollment on 22 health plans with about 152,000 customers.
President Barack Obama sent a letter (.pdf) to House Speaker Nancy Pelosi (D-Calif.) Wednesday asking the Congress "for $2.8 billion in emergency funds to provide for costs associated with relief and reconstruction for Haiti, after its devastating earthquake on January 12," Reuters reports.
Ten years before the 1973 Supreme Court decision legalizing abortion - which likely will be a focus of Senate confirmation questions for Supreme Court nominee Elena Kagan next week - German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J. Reagan says in a new book.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
› Verified 4 days ago
| NPI Number | 1255590162 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 73 Eastern Steel Rd, Milford, CT 06460 |
| Phone Number | 203-877-2249 |
News Archive
California Insurance Commissioner Dave Jones denied Blue Shield of California's plan to close several of its health policies to new customers, saying it violated state rules designed to protect consumers from large rate increases. ... Blue Shield, a nonprofit insurer with 3.3 million members statewide, had proposed closing off new enrollment on 22 health plans with about 152,000 customers.
President Barack Obama sent a letter (.pdf) to House Speaker Nancy Pelosi (D-Calif.) Wednesday asking the Congress "for $2.8 billion in emergency funds to provide for costs associated with relief and reconstruction for Haiti, after its devastating earthquake on January 12," Reuters reports.
Ten years before the 1973 Supreme Court decision legalizing abortion - which likely will be a focus of Senate confirmation questions for Supreme Court nominee Elena Kagan next week - German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J. Reagan says in a new book.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
› Verified 4 days ago
News Archive
California Insurance Commissioner Dave Jones denied Blue Shield of California's plan to close several of its health policies to new customers, saying it violated state rules designed to protect consumers from large rate increases. ... Blue Shield, a nonprofit insurer with 3.3 million members statewide, had proposed closing off new enrollment on 22 health plans with about 152,000 customers.
President Barack Obama sent a letter (.pdf) to House Speaker Nancy Pelosi (D-Calif.) Wednesday asking the Congress "for $2.8 billion in emergency funds to provide for costs associated with relief and reconstruction for Haiti, after its devastating earthquake on January 12," Reuters reports.
Ten years before the 1973 Supreme Court decision legalizing abortion - which likely will be a focus of Senate confirmation questions for Supreme Court nominee Elena Kagan next week - German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J. Reagan says in a new book.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Silence Therapeutics plc announces the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark Office. The issued patent, which is based on the seminal research of Phillip D. Zamore, Ph.D., Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair of Biomedical Sciences, and Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School, generally claims methods of enhancing the RNA silencing activity of RNA interference (RNAi) agents through certain structural modifications.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 73 Eastern Steel Rd, Milford, Connecticut 06460 Phone: (203) 877-2249 | |
Byram Healthcare Centers, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 185 Plains Rd, Milford, Connecticut 06461 Phone: (203) 701-0390 | |
Cvs Pharmacy #00071 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 989 Boston Post Rd, Milford, Connecticut 06460 Phone: (203) 783-9058 | |
Cvs Pharmacy #01241 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 734 Bridgeport Ave, Milford, Connecticut 06460 Phone: (203) 877-8127 | |
Cvs Pharmacy #17137 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1191 Boston Post Rd, Milford, Connecticut 06460 Phone: (203) 306-5064 |